Latest Blog Posts Tagged "Treatment Goal"
Podcast: Drug That May Slow Parkinson's Progression Granted $23 Million from NIH for Phase III Testing
March 31, 2014
Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.
October 29, 2013
Contributing Editor Dave Iverson reports on the new technology that partnership will employ and the current state of stem cell research in Parkinson's disease. He speaks
November 08, 2012
The obstacles to bringing new Parkinson's disease (PD) drugs to market are many, and they span all stages of the drug development pipeline.